Neocuproine

Neocuproine (CAS No.: 484-11-7) is a phenanthroline-derived organic chelating agent widely employed in chemical biology and biomedical research as a selective complexing reagent for copper ions. By forming highly stable complexes with copper, particularly in its reduced state, Neocuproine serves as a sensitive detector of copper ions and a functional modulator of copper-dependent redox processes, thereby influencing oxidative and reductive reaction pathways. This compound is commonly utilized to probe copper-mediated signaling mechanisms, including those associated with oxidative stress, mitochondrial function, and metal homeostasis, and is frequently applied in studies investigating the role of copper dysregulation in neurodegenerative diseases and other metabolic disorders. In addition to its analytical applications, Neocuproine can act as a ligand in transition metal-catalyzed transformations and has utility in synthetic methodologies such as aryl ketone formation. In vitro, its activity is generally characterized by effective copper chelation in the low micromolar range, although precise activity profiles depend on experimental conditions and system context. In cell-based and biochemical assays, it is routinely used to modulate intracellular copper availability or to inhibit copper-dependent enzymatic processes, while in vivo applications remain largely exploratory and dependent on study design. Overall, Neocuproine represents a versatile tool compound for investigating copper biology and redox-regulated pathways in drug discovery and mechanistic research.